Single-nucleus RNA sequencing of temporal neocortex showed nominally increased mosaic chromosomal alterations associated with clonal hematopoiesis; microglia carrying mCA exhibited upregulated pro-inf

Gene_Expression Score: 0.500 Price: $0.50 Alzheimer's disease in_vivo Status: extracted

What This Experiment Tests

Gene_Expression experiment designed to assess clinical efficacy targeting pro-inflammatory genes; DAM signature genes in in_vivo. Primary outcome: Single-nucleus RNA sequencing of temporal neocortex showed nominally increased mosaic chromosomal al

Description

snRNAseq analysis of 62 additional AD cases and controls; mosaic chromosomal alteration (mCA) detection

TARGET GENE
pro-inflammatory genes; DAM signature genes
MODEL SYSTEM
in_vivo
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
neuroinflammation; disease-associated microglia (DAM) pathway
SOURCE
pmid_38260600
PRIMARY OUTCOME
Single-nucleus RNA sequencing of temporal neocortex showed nominally increased mosaic chromosomal alterations associated with clonal hematopoiesis; microglia carrying mCA exhibited upregulated pro-inflammatory genes resembling disease-associated microglia (DAM) signature.

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.500 composite

Related Hypotheses (1)

APOE4-Specific Proteolytic Fragment Inhibition Therapy0.777

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.